Guest Speaker: Dr. Todd D. Cohen, Medical Director at Myriad Genetics
Thomas Farrington, PHEN President, outlines why genomic biomarker testing is needed by African American patients before they choose active surveillance....
The “Daddy’s Boys” stage play, presented on tour by PHEN, draws 1,000+ national attendees per performance.
Prostate caner, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline.
New research shows that African American men who receive treatments for late-stage prostate cancer can live at least as long, or even longer than their Caucasian counterparts.
African-American men with metastatic castration-resistant prostate cancer and no chemotherapy lived significantly longer than white men when treated with newer hormonal therapies.